Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of ONTAK With Metastatic Melanoma

NCT00299689 is registered in ClinicalTrials.gov with James Graham Brown Cancer Center as lead sponsor.

NCT NCT00299689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00299689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of ONTAK With Metastatic Melanoma
Lead sponsor
James Graham Brown Cancer Center
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2006
Completion date
January 31, 2010
Enrollment
69 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant melanoma